Results 191 to 200 of about 2,878,616 (306)

Patient-Reported Outcome Measures Used in Primary Hyperparathyroidism: A Scoping Review. [PDF]

Ann Surg Oncol
Leblang CL, Ahmed M, Wade CG, Cho NL, Doherty GM, Nehs MA, Liu JB.   +6 more
europepmc   +1 more source

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

Molecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, Laura Sichero, Patrícia Savio de Araujo‐Souza, Fabio Passetti, Luisa Lina Villa   +6 more
wiley   +1 more source

Development of a New Patient-Reported Outcome to Measure Fatigue in Patients with Multiple Sclerosis. [PDF]

Nurs Rep
Jorquera-Ruzzi MA, Ramo Tello C, Durà-Mata MJ, Casas I.   +3 more
europepmc   +1 more source

Network divergence analysis identifies adaptive gene modules and two orthogonal vulnerability axes in pancreatic cancer

Molecular Oncology, EarlyView.
Tumors contain diverse cellular states whose behavior is shaped by context‐dependent gene coordination. By comparing gene–gene relationships across biological contexts, we identify adaptive transcriptional modules that reorganize into distinct vulnerability axes.
Brian Nelson, Lyanne Delgado‐Coka, Natalia Marchenko, Luisa F. Escobar‐Hoyos, Kenneth R. Shroyer, Alisa Yurovsky, Trey Ideker, Gábor Balázsi, Thomas MacCarthy, Scott Powers   +9 more
wiley   +1 more source

Barriers and facilitators for implementing patient-reported outcome measures in oncology practices: an umbrella review. [PDF]

Qual Life Res
Rammant E, Ramsey I, M de Ligt K, Mazariego C, Pogoda K, Schmidt H, Beernaert K, Lidington E, Javan RC, Koczwara B, Sztankay M, van de Poll-Franse L, Van Hemelrijck M, EORTC quality of life group.   +13 more
europepmc   +1 more source

RIPK4 function interferes with melanoma cell adhesion and metastasis

Molecular Oncology, EarlyView.
RIPK4 promotes melanoma growth and spread. RIPK4 levels increase as skin lesions progress to melanoma. CRISPR/Cas9‐mediated deletion of RIPK4 causes melanoma cells to form less compact spheroids, reduces their migratory and invasive abilities and limits tumour growth and dissemination in mouse models.
Norbert Wronski, Sławomir Lasota, Ewelina Madej, Anna A. Brożyna, Małgorzata Szczygieł, Agnieszka Harazin‐Lechowska, Jan Czerbniak, Janusz Rys, Jaroslaw Czyz, Agnieszka Wolnicka‐Glubisz   +9 more
wiley   +1 more source

Analyzing the Readability of Facial Paralysis Patient-Reported Outcome Measures. [PDF]

J Otolaryngol Head Neck Surg
Desai S, Russel SM, Lee S, Farzal Z, Miller MQ.   +4 more
europepmc   +1 more source

COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells

Molecular Oncology, EarlyView.
This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos, Gilar Gorji‐bahri, Lejla Gradjan, Julia Zajac, Kacper Gil, Yvonne Thokozile Nduku, Anna M. Blom   +6 more
wiley   +1 more source

Correction: Patient‑reported outcome (PRO) instruments used in patients undergoing adoptive cell therapy (ACT) for the treatment of cancer: a systematic review

Systematic Reviews
Sally Taylor, Kate Law, Jake Coomber‑Moore, Michelle Davies, Fiona Thistlethwaite, Mel Calvert, Olalekan Aiyegbusi, Janelle Yorke   +7 more
doaj   +1 more source

Language concordance in the digital collection of patient-reported outcome measures. [PDF]

JAMIA Open
Liu JB, Dacier BM, Dragonetti BM, Meyers PM, Sisodia RC, Park LH, Pusic AL, Ortega G.   +7 more
europepmc   +1 more source